We call it massiiiiiiivve. PE at St Emlyn’s
I have been asked to talk about the diagnosis of massive PE for the upcoming EUSEM congress in Glasgow this month. We have blogged on this before1, but it’s a thorny issue and one that …
JC: TICH TICH BOOM? TXA in ICH. St Emlyn’s
TXA. Huh. Good god y’all. What is it good for? Absolutely everything. This appears to be the alternative hypothesis for the TICH-2 study 1, published last week in the Lancet. Off the back of recent …
Complications of anticoagulation and how to manage them. St Emlyn’s
So, this was the lecture title I was given for the RCEM CPD conference this year for the geriatric medicine session. Quite the opposite of what I usually talk about, which is thrombosis and why …
JC: So long Salt and Saline? St Emlyn’s
Simon has already covered the recent SMART trial1, regarding the comparison of balanced crystalloid solutions versus normal saline for resuscitation in critically ill adults. However, there was another paper in the same edition of the …
The End of the ‘Roid? JC: ADRENAL
So another year, another Critical Care Reviews meeting. Rob is doing an absolutely fantastic job with these, inviting lead authors from major critical care trials to present and defend their work. In fact, this is …
Dan does part of State of the Art #ICSSOA2017. St.Emlyn’s
St Emlyn’s were on tour again this week, and I was lucky enough to attend the yearly UK Intensive Care Society State of the Art (ICSSOA) 2017 Conference in Liverpool. This is always a great …
RCEM ASC 2017 – Update on the TiLLI study
It is the week of the annual scientific conference for the Royal College of Emergency Medicine again. As usual the St Emlyns team is in the thick of it and when someone mentioned clots I …
The rise and SURPRISE of the DOACs. St.Emlyn’s
Been a while since we have had any clotology on here. That is unacceptable. So here we go with another journal club fest on the management of acute VTE. Now we have improved access to …
JC: Vitamin SCepTiC?
We all love the idea of a magic bullet for sepsis. Despite having had our fingers burnt here before (like this time, and this time and that time…), the search continues …
Hypothermia in status epilepticus. St.Emlyn’s
It seems as though hypothermia is the therapy that never quite gets there. The Targeted Temperature Management1,2 trial showed no benefit post ROSC and the RINSE trial 3,4 showed no benefit before ROSC. We’ve also …